Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HCV NS3 protease inhibitors

HCV NS3 protease inhibitors

US Patent 8461107 · Granted Jun 11, 2013

Estimated economic value: $101,070,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Antimalarial agents2025
Antimalarial agents2025
Pyrrolidine orexin receptor agonists2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
Phosphinic amide prodrugs of tenofovir2023
Bicycloheptane pyrrolidine orexin receptor agonists2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2022